Skip to content
Gallery
Tables
ESG Matters
6_planning-your-transportation-transition
5_HE_NIL-opportunities
5 Leveraging-governance
Potential Capital Gains Table 3
Potential Capital Gains Table 2
Test without special characters
Test with HTML characters
4_EU_utilitys-asset-records-t1
4_EU_utilitys-asset-records-t2
4_EU_utilitys-asset-records-t3
4_EU_utility-assets-t1
4_EU_utility-assets-t2
4_EU_utility-assets3
4_TAX_RE-increases
Firm_Consumer-Privacy-Policy
Life sciences industry forecast for 2022 and beyond
NCAA Constitution
Cash vs Accrual Accounting
2_FaaS_Reporting packages
2_FaaS_dashboards-financial-reporting
More
Share
Explore

Life sciences industry forecast for 2022 and beyond

Agenda
1
Opening remarks
⁠
Darren Jones, CIA, Principal
⁠
⁠
2
Trends in capital markets and corporate governance
⁠
Mike Green, CPA, Partner
⁠
⁠
3
Changes to the commercial landscape
⁠
John Finan, MBA, Director
⁠
4
Opportunities for real-world data (RWD) and health economics and outcomes research (HEOR)
⁠
Keith Needham, Senior manager
⁠
⁠
5
Strategies to translate RWD to commercial strategies
⁠
David Gregory, MPA, FACHE, Principal
⁠
⁠
6
Challenges and trends in healthcare professional (HCP) and patient engagement
⁠
Samantha Sutherland, Director
⁠
⁠
7
Impacts of the ever-evolving regulatory landscape
⁠
Mark Scallon, MHA, Principal
⁠
⁠
8
Closing remarks and Q&A
⁠
Darren Jones, CIA, Principal
⁠
⁠
There are no rows in this table
⁠

Want to print your doc?
This is not the way.
Try clicking the ⋯ next to your doc name or using a keyboard shortcut (
CtrlP
) instead.